Magnetic resonance imaging and machine learning make a valuable combined tool for the screening of preclinical AD
View/Open
ARTICLE (95,46Kb) (Restricted access)
Request copy
Document typeArticle
Defense date2017-07
Rights accessRestricted access - publisher's policy
(embargoed until 2022-02)
European Commission's projectNPAD - Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (EC-H2020-707730)
CitationPetrone, P., Vilaplana, V., Casamitjana, A., Domingo-Gispert, J., Molinuevo, J., Sánchez, D. Magnetic resonance imaging and machine learning make a valuable combined tool for the screening of preclinical AD. "Alzheimer's and dementia", Juliol 2017, vol. 13, núm. 7, p. 1245.
ISSN1552-5260
| Files | Description | Size | Format | View |
|---|---|---|---|---|
Vilaplana_Petrone.pdf | ARTICLE | 95,46Kb | Restricted access |
Except where otherwise noted, content on this work
is licensed under a Creative Commons license
:
Attribution-NonCommercial-NoDerivs 3.0 Spain